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Biobanks, repositories of human biospecimen (tissue,
blood, bone, serum, DNA, RNA etc.) are critical resources
enabling association of patients phenotypic to molecular
data. Biospecimen of controlled quality thus are manda-
tory prerequisites for precise multiparameter diagnosis,
individualized biomarker-based treatment and prognosis
and therefore, are critical for the development of persona-
lized medicine in general.
This paper will address current and future challenges
and projects in biobanking including biospecimen storage
conditions (standardized storage conditions or validation
of storage conditions impact) in the light of changing
technologies and future data analysis reflecting the fact
that technological and medical knowledge evolve over
time. The lack of standardization in clinical study report-
ing is another issue preventing annotation of pseudony-
mized individual molecular and clinical data and thus
further analyses. Further, the importance of adequate
funding, training and certification will be stressed, sugges-
tions for biobank quality criteria presented and aspects
such as quality management, biobank network extension
and resource sharing discussed.
To tackle these issues, ESBB’s potential future partners
and possible proposals within the new EU Program
“Horizon 2020” will be introduced.
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